Therapy-related CD7+ acute myeloid leukemia with trisomy 8 following acute monocytic leukemia.

Abstract

We report a patient who developed CD7+ therapy-related acute myeloid leukemia (t-AML) with trisomy 8 after chemotherapy for AML.

• Authors: M Tanaka, H Kanamori, S Yamaji, K Fujimaki, N Tomita, S Fujisawa, Y Ishigatsubo
• Journal: Anti-cancer drugs (Anticancer Drugs) Vol. 12 Issue 8 Pg. 681-2 (Sep 2001) ISSN: 0959-4973 [Print] England
• PMID: 11604555 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antigens, CD7
• Biomarkers, Tumor
• Cytarabine
• Prednisolone
• enocitabine
• Mercaptopurine
• Daunorubicin

Topics

• Antigens, CD7 (analysis)
• Biomarkers, Tumor (analysis)
• Chromosomes, Human, Pair 8 (genetics)
• Cytarabine (adverse effects, analogs & derivatives, therapeutic use)
• Daunorubicin (therapeutic use)
• Diagnosis, Differential
• Female
• Humans
• Leukemia, Monocytic, Acute (diagnosis, drug therapy)
• Leukemia, Myeloid (chemically induced, diagnosis, genetics)
• Mercaptopurine (therapeutic use)
• Middle Aged
• Neoplasms, Second Primary (chemically induced, diagnosis, genetics)
• Prednisolone (therapeutic use)
• Trisomy (genetics)